Your browser doesn't support javascript.
loading
Potential mouse models of coronavirus-related immune injury.
Nan, Fu-Yao; Wu, Cai-Jun; Su, Jia-Hui; Ma, Lin-Qin.
Afiliación
  • Nan FY; Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
  • Wu CJ; Department of Emergency Medicine, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
  • Su JH; Institute of Sepsis, Beijing University of Chinese Medicine, Beijing, China.
  • Ma LQ; Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Front Immunol ; 13: 943783, 2022.
Article en En | MEDLINE | ID: mdl-36119040
ABSTRACT
Basic research for prevention and treatment of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues worldwide. In particular, multiple newly reported cases of autoimmune-related diseases after COVID-19 require further research on coronavirus-related immune injury. However, owing to the strong infectivity of SARS-CoV-2 and the high mortality rate, it is difficult to perform relevant research in humans. Here, we reviewed animal models, specifically mice with coronavirus-related immune disorders and immune damage, considering aspects of coronavirus replacement, viral modification, spike protein, and gene fragments. The evaluation of mouse models of coronavirus-related immune injury may help establish a standardised animal model that could be employed in various areas of research, such as disease occurrence and development processes, vaccine effectiveness assessment, and treatments for coronavirus-related immune disorders. COVID-19 is a complex disease and animal models cannot comprehensively summarise the disease process. The application of genetic technology may change this status.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases Asunto principal: Glicoproteína de la Espiga del Coronavirus / COVID-19 Límite: Animals / Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases Asunto principal: Glicoproteína de la Espiga del Coronavirus / COVID-19 Límite: Animals / Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China
...